Lupin is partnering with Mark Cuban Cost Plus Drug Company and the COPD Foundation, in an effort to bolster access to health care by expanding the availability of Tiotropium Bromide Inhalation Powder, ...
Research on Chronic Obstructive Pulmonary Disease (COPD) requires further examination of rural health disparities and the impact of sociocultural and environmental exposures on health outcomes, ...
Prevalence of chronic obstructive pulmonary disease (COPD) and the disease's burden varies significantly by state. Understanding this variation could help address public health gaps to ease the burden ...
Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to a new study published in Chronic Obstructive Pulmonary Diseases: Journal ...
Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with multinational pharmaceutical company Lupin Limited and the COPD Foundation to expand access to Tiotropium Bromide Inhalation Powder for ...
Hosted on MSN
Increased patient–provider communication, education about COPD needed to improve patient care
Prioritizing communications between patients and health care providers and increasing patient education about chronic obstructive pulmonary disease (COPD) could help improve patient care, according to ...
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)-- Patients with chronic obstructive pulmonary disease (COPD) face significant challenges, but conversations with healthcare providers can play a ...
Miami (November 14, 2024) – Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD and establish how the chronic lung disease ...
Miami (June 24, 2025) – Prevalence of chronic obstructive pulmonary disease (COPD) and the disease’s burden varies significantly by state. Understanding this variation could help address public health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results